{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T07:04:09Z","timestamp":1793343849653,"version":"4.5.0"},"reference-count":101,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T00:00:00Z","timestamp":1721606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005688","name":"Gottfried und Julia Bangerter-Rhyner-Stiftung","doi-asserted-by":"publisher","award":["YTCR 08\/20"],"award-info":[{"award-number":["YTCR 08\/20"]}],"id":[{"id":"10.13039\/501100005688","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005688","name":"Gottfried und Julia Bangerter-Rhyner-Stiftung","doi-asserted-by":"publisher","award":["YTCR 32\/18"],"award-info":[{"award-number":["YTCR 32\/18"]}],"id":[{"id":"10.13039\/501100005688","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008485","name":"Schweizerische Akademie der Medizinischen Wissenschaften","doi-asserted-by":"publisher","award":["323530-191230"],"award-info":[{"award-number":["323530-191230"]}],"id":[{"id":"10.13039\/501100008485","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006447","name":"Universit\u00e4t Z\u00fcrich","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006447","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["310030-200669"],"award-info":[{"award-number":["310030-200669"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["PCEFP3_181249"],"award-info":[{"award-number":["PCEFP3_181249"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["310030-172978"],"award-info":[{"award-number":["310030-172978"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunity"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.immuni.2024.07.016","type":"journal-article","created":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T10:38:48Z","timestamp":1723459128000},"page":"2232-2250.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["Interleukin-2 immunotherapy reveals human regulatory T\u00a0cell subsets with distinct functional and tissue-homing characteristics"],"prefix":"10.1016","volume":"57","author":[{"given":"Miro E.","family":"Raeber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic P.","family":"Caspar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Zurbuchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nannan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Michler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina C.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urs C.","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas E.","family":"Moor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frits","family":"Koning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8279-5545","authenticated-orcid":false,"given":"Onur","family":"Boyman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.immuni.2024.07.016_bib1","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T\u00a0cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2024.07.016_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.648408","article-title":"Low-Dose IL-2 Therapy in Autoimmune and Rheumatic Diseases","volume":"12","author":"Gra\u00dfhoff","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.immuni.2024.07.016_bib3","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/s41577-022-00680-w","article-title":"Engineering IL-2 for immunotherapy of autoimmunity and cancer","volume":"22","author":"Hernandez","year":"2022","journal-title":"Nat.\u00a0Rev. Immunol."},{"key":"10.1016\/j.immuni.2024.07.016_bib4","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nri3823","article-title":"The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases","volume":"15","author":"Klatzmann","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2024.07.016_bib5","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.immunol.25.022106.141623","article-title":"Regulatory T\u00a0cells: mechanisms of differentiation and function","volume":"30","author":"Josefowicz","year":"2012","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.immuni.2024.07.016_bib6","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/nri3156","article-title":"The role of interleukin-2 during homeostasis and activation of the immune system","volume":"12","author":"Boyman","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2024.07.016_bib7","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abo5409","article-title":"Interleukin-2-based therapies in cancer","volume":"14","author":"Raeber","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.immuni.2024.07.016_bib8","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.2337\/db14-1322","article-title":"Selective IL-2 responsiveness of regulatory T\u00a0cells through multiple intrinsic mechanisms supports the use of low-dose IL-2 therapy in type 1 diabetes","volume":"64","author":"Yu","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.immuni.2024.07.016_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104539","article-title":"A systematic review of interleukin-2-based immunotherapies in clinical trials for cancer and autoimmune diseases","volume":"90","author":"Raeber","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.immuni.2024.07.016_bib10","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1136\/annrheumdis-2015-207776","article-title":"Low-dose interleukin-2 selectively corrects regulatory T\u00a0cell defects in patients with systemic lupus erythematosus","volume":"75","author":"von Spee-Mayer","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.immuni.2024.07.016_bib11","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/S2665-9913(19)30018-9","article-title":"Low-dose interleukin-2 therapy in refractory systemic lupus erythematosus: an investigator-initiated, single-centre phase 1 and 2a clinical trial","volume":"1","author":"Humrich","year":"2019","journal-title":"Lancet Rheumatol."},{"key":"10.1016\/j.immuni.2024.07.016_bib12","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1056\/NEJMoa1108188","article-title":"Interleukin-2 and regulatory T\u00a0cells in graft-versus-host disease","volume":"365","author":"Koreth","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2024.07.016_bib13","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1056\/NEJMoa1105143","article-title":"Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis","volume":"365","author":"Saadoun","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2024.07.016_bib14","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.147474","article-title":"The effect of low-dose IL-2 and Treg adoptive cell therapy in patients with type 1 diabetes","volume":"6","author":"Dong","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.immuni.2024.07.016_bib15","doi-asserted-by":"crossref","first-page":"7324","DOI":"10.1038\/s41467-022-34162-3","article-title":"Low-dose IL-2 reduces IL-21(+) T\u00a0cell frequency and induces anti-inflammatory gene expression in type 1 diabetes","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2024.07.016_bib16","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41573-019-0041-4","article-title":"Next-generation regulatory T\u00a0cell therapy","volume":"18","author":"Ferreira","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.immuni.2024.07.016_bib17","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMra1100359","article-title":"Systemic lupus erythematosus","volume":"365","author":"Tsokos","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2024.07.016_bib18","doi-asserted-by":"crossref","first-page":"16039","DOI":"10.1038\/nrdp.2016.39","article-title":"Systemic lupus erythematosus","volume":"2","author":"Kaul","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.immuni.2024.07.016_bib19","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJMoa2308917","article-title":"CD19 CAR T-Cell Therapy in Autoimmune Disease - A Case Series with Follow-up","volume":"390","author":"M\u00fcller","year":"2024","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2024.07.016_bib20","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.it.2017.02.001","article-title":"Expanding the B Cell-Centric View of Systemic Lupus Erythematosus","volume":"38","author":"Morawski","year":"2017","journal-title":"Trends Immunol."},{"key":"10.1016\/j.immuni.2024.07.016_bib21","doi-asserted-by":"crossref","DOI":"10.1126\/science.abf1970","article-title":"Single-cell RNA-seq reveals cell type-specific molecular and genetic associations to lupus","volume":"376","author":"Perez","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.immuni.2024.07.016_bib22","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1016\/j.cell.2022.07.021","article-title":"Distinct transcriptome architectures underlying lupus establishment and exacerbation","volume":"185","author":"Nakano","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2024.07.016_bib23","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1136\/ard-2022-222501","article-title":"Low-dose interleukin-2 therapy in active systemic lupus erythematosus (LUPIL-2): a multicentre, double-blind, randomised and placebo-controlled phase II trial","volume":"81","author":"Humrich","year":"2022","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.immuni.2024.07.016_bib24","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/annrheumdis-2018-214229","article-title":"Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial","volume":"78","author":"Rosenzwajg","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.immuni.2024.07.016_bib25","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nm.4148","article-title":"Low-dose interleukin-2 treatment selectively modulates CD4(+) T\u00a0cell subsets in patients with systemic lupus erythematosus","volume":"22","author":"He","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2024.07.016_bib26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/annrheumdis-2019-215396","article-title":"Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial","volume":"79","author":"He","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.immuni.2024.07.016_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aba5464","article-title":"Interleukin-2 signals converge in a lymphoid-dendritic cell pathway that promotes anticancer immunity","volume":"12","author":"Raeber","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.immuni.2024.07.016_bib28","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/s41590-022-01179-1","article-title":"Dynamic transcriptional activity and chromatin remodeling of regulatory T\u00a0cells after varied duration of interleukin-2 receptor signaling","volume":"23","author":"Moro","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2024.07.016_bib29","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.immuni.2023.01.004","article-title":"Principles of regulatory T\u00a0cell function","volume":"56","author":"Dikiy","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2024.07.016_bib30","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41581-023-00733-w","article-title":"Regulatory T\u00a0cells in autoimmune kidney diseases and transplantation","volume":"19","author":"Mikami","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.immuni.2024.07.016_bib31","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1038\/s41590-019-0472-4","article-title":"Follicular regulatory T\u00a0cells control humoral and allergic immunity by restraining early B cell responses","volume":"20","author":"Clement","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2024.07.016_bib32","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/ni.1731","article-title":"The transcription factor T-bet controls regulatory T\u00a0cell homeostasis and function during type 1 inflammation","volume":"10","author":"Koch","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2024.07.016_bib33","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nature07674","article-title":"Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses","volume":"458","author":"Zheng","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2024.07.016_bib34","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1126\/science.1172702","article-title":"CD4+ regulatory T\u00a0cells control TH17 responses in a Stat3-dependent manner","volume":"326","author":"Chaudhry","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.immuni.2024.07.016_bib35","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/mi.2015.74","article-title":"Foxp3(+) T\u00a0cells expressing RORgammat represent a stable regulatory T-cell effector lineage with enhanced suppressive capacity during intestinal inflammation","volume":"9","author":"Yang","year":"2016","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.immuni.2024.07.016_bib36","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41577-023-00890-w","article-title":"Regulatory T\u00a0cells in the face of the intestinal microbiota","volume":"23","author":"Ramanan","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2024.07.016_bib37","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.immuni.2007.02.009","article-title":"Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation","volume":"26","author":"Laurence","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2024.07.016_bib38","article-title":"Soluble PD-L1 as an early marker of progressive disease on nivolumab","volume":"10","author":"Mahoney","year":"2022","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.immuni.2024.07.016_bib39","doi-asserted-by":"crossref","first-page":"160.14","DOI":"10.4049\/jimmunol.208.Supp.160.14","article-title":"CEACAM1 is an IL-2R-dependent biomarker in patients with multiple autoimmune-diseases undergoing low-dose IL-2 therapy","volume":"208","author":"Yu","year":"2022","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2024.07.016_bib40","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89160","article-title":"Foxp3 drives oxidative phosphorylation and protection from lipotoxicity","volume":"2","author":"Howie","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.immuni.2024.07.016_bib41","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005265","article-title":"Low-dose interleukin-2 therapy restores regulatory T\u00a0cell homeostasis in patients with chronic graft-versus-host disease","volume":"5","author":"Matsuoka","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.immuni.2024.07.016_bib42","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1038\/s41590-020-0769-3","article-title":"The PD-1 expression balance between effector and regulatory T\u00a0cells predicts the clinical efficacy of PD-1 blockade therapies","volume":"21","author":"Kumagai","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2024.07.016_bib43","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/s41590-023-01469-2","article-title":"How autoreactive thymocytes differentiate into regulatory versus effector CD4(+) T\u00a0cells after avoiding clonal deletion","volume":"24","author":"Tai","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2024.07.016_bib44","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.immuni.2019.01.020","article-title":"Human FOXP3(+) Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer","volume":"50","author":"Wing","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2024.07.016_bib45","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41577-023-00960-z","article-title":"Brain regulatory T\u00a0cells","volume":"24","author":"Liston","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2024.07.016_bib46","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12867-018-0106-7","article-title":"Quantitative profiling of BATF family proteins\/JUNB\/IRF hetero-trimers using Spec-seq","volume":"19","author":"Chang","year":"2018","journal-title":"BMC Mol. Biol."},{"key":"10.1016\/j.immuni.2024.07.016_bib47","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/s41577-023-00893-7","article-title":"The role of transcription factors in shaping regulatory T\u00a0cell identity","volume":"23","author":"Trujillo-Ochoa","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2024.07.016_bib48","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.immuni.2019.12.002","article-title":"Precursors for Nonlymphoid-Tissue Treg Cells Reside in Secondary Lymphoid Organs and Are Programmed by the Transcription Factor BATF","volume":"52","author":"Delacher","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2024.07.016_bib49","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adf6717","article-title":"Integrated BATF transcriptional network regulates suppressive intratumoral regulatory T\u00a0cells","volume":"8","author":"Shan","year":"2023","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.immuni.2024.07.016_bib50","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41577-021-00519-w","article-title":"Tissue regulatory T\u00a0cells: regulatory chameleons","volume":"21","author":"Mu\u00f1oz-Rojas","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2024.07.016_bib51","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/imm.13178","article-title":"Control of regulatory T-cell differentiation and function by T-cell receptor signalling and Foxp3 transcription factor complexes","volume":"160","author":"Ono","year":"2020","journal-title":"Immunology"},{"key":"10.1016\/j.immuni.2024.07.016_bib52","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1146\/annurev-immunol-032713-120145","article-title":"Chemokines and chemokine receptors: positioning cells for host defense and immunity","volume":"32","author":"Griffith","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.immuni.2024.07.016_bib53","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1152\/physrev.00036.2018","article-title":"Cell Adhesion by Integrins","volume":"99","author":"Bachmann","year":"2019","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.immuni.2024.07.016_bib54","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.immuni.2009.11.009","article-title":"CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients","volume":"32","author":"Blair","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2024.07.016_bib55","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.immuni.2018.08.015","article-title":"Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus","volume":"49","author":"Jenks","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2024.07.016_bib56","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nri1917","article-title":"Balancing co-stimulation and inhibition with BTLA and HVEM","volume":"6","author":"Murphy","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2024.07.016_bib57","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/s41467-023-36924-z","article-title":"Biased IL-2 signals induce Foxp3-rich pulmonary lymphoid structures and facilitate long-term lung allograft acceptance in mice","volume":"14","author":"Yamada","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2024.07.016_bib58","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.4049\/jimmunol.1300212","article-title":"Cutting Edge: memory regulatory T\u00a0cells require IL-7 and not IL-2 for their maintenance in peripheral tissues","volume":"190","author":"Gratz","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2024.07.016_bib59","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/imr.12644","article-title":"The role of cytokines in T-cell memory in health and disease","volume":"283","author":"Raeber","year":"2018","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.immuni.2024.07.016_bib60","doi-asserted-by":"crossref","first-page":"5941","DOI":"10.1073\/pnas.0601335103","article-title":"Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis","volume":"103","author":"Bielekova","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2024.07.016_bib61","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.4049\/jimmunol.1502570","article-title":"Human CD56bright NK Cells: An Update","volume":"196","author":"Michel","year":"2016","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2024.07.016_bib62","doi-asserted-by":"crossref","first-page":"6757","DOI":"10.1038\/s41467-022-34477-1","article-title":"Costimulation blockade in combination with IL-2 permits regulatory T\u00a0cell sparing immunomodulation that inhibits autoimmunity","volume":"13","author":"Wang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2024.07.016_bib63","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.4049\/jimmunol.176.8.4622","article-title":"MHC class II expression identifies functionally distinct human regulatory T\u00a0cells","volume":"176","author":"Baecher-Allan","year":"2006","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2024.07.016_bib64","doi-asserted-by":"crossref","first-page":"11977","DOI":"10.3390\/ijms222111977","article-title":"CD38 Correlates with an Immunosuppressive Treg Phenotype in Lupus-Prone Mice","volume":"22","author":"P\u00e9rez-Lara","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.immuni.2024.07.016_bib65","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.154646","article-title":"Multiplexed single-cell analysis reveals prognostic and nonprognostic T\u00a0cell types in human colorectal cancer","volume":"7","author":"Masuda","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.immuni.2024.07.016_bib66","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1056\/NEJMoa2023325","article-title":"Targeting CD38 with Daratumumab in Refractory Systemic Lupus Erythematosus","volume":"383","author":"Ostendorf","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2024.07.016_bib67","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1182\/blood-2015-12-687749","article-title":"Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma","volume":"128","author":"Krejcik","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.immuni.2024.07.016_bib68","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1038\/s41467-023-37424-w","article-title":"Low-dose IL-2 enhances the generation of IL-10-producing immunoregulatory B cells","volume":"14","author":"Inaba","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2024.07.016_bib69","doi-asserted-by":"crossref","first-page":"11906","DOI":"10.1073\/pnas.1002569107","article-title":"Improved IL-2 immunotherapy by selective stimulation of IL-2 receptors on lymphocytes and endothelial cells","volume":"107","author":"Krieg","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2024.07.016_bib70","doi-asserted-by":"crossref","DOI":"10.1126\/science.aay5947","article-title":"An atlas of the protein-coding genes in the human, pig, and mouse brain","volume":"367","author":"Sj\u00f6stedt","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.immuni.2024.07.016_bib71","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/s41591-018-0070-2","article-title":"A human anti-IL-2 antibody that potentiates regulatory T\u00a0cells by a structure-based mechanism","volume":"24","author":"Trotta","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2024.07.016_bib72","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb9283","article-title":"Receptor-gated IL-2 delivery by an anti-human IL-2 antibody activates regulatory T\u00a0cells in three different species","volume":"12","author":"Karakus","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.immuni.2024.07.016_bib73","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.immuni.2024.07.016_bib74","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1056\/NEJMoa051135","article-title":"Combined oral contraceptives in women with systemic lupus erythematosus","volume":"353","author":"Petri","year":"2005","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2024.07.016_bib75","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/rheumatology\/kep064","article-title":"The BILAG-2004 index is sensitive to change for assessment of SLE disease activity","volume":"48","author":"Yee","year":"2009","journal-title":"Rheumatol. Oxf. Engl."},{"key":"10.1016\/j.immuni.2024.07.016_bib76","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1093\/rheumatology\/keq026","article-title":"Numerical scoring for the BILAG-2004 index","volume":"49","author":"Yee","year":"2010","journal-title":"Rheumatol. Oxf. Engl."},{"key":"10.1016\/j.immuni.2024.07.016_bib77","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/art.24698","article-title":"Novel evidence-based systemic lupus erythematosus responder index","volume":"61","author":"Furie","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.immuni.2024.07.016_bib78","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/s41590-023-01497-y","article-title":"Human memory B cells show plasticity and adopt multiple fates upon recall response to SARS-CoV-2","volume":"24","author":"Zurbuchen","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2024.07.016_bib79","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.12688\/f1000research.26073.1","article-title":"An R-based reproducible and user-friendly preprocessing pipeline for CyTOF data","volume":"9","author":"Crowell","year":"2020","journal-title":"F1000Res"},{"key":"10.1016\/j.immuni.2024.07.016_bib80","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/cyto.a.22625","article-title":"FlowSOM: Using self-organizing maps for visualization and interpretation of cytometry data","volume":"87","author":"Van Gassen","year":"2015","journal-title":"Cytometry A"},{"key":"10.1016\/j.immuni.2024.07.016_bib81","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cell.2015.05.047","article-title":"Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with Prognosis","volume":"162","author":"Levine","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2024.07.016_bib82","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41590-018-0294-9","article-title":"Memory CD4(+) T\u00a0cells are generated in the human fetal intestine","volume":"20","author":"Li","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2024.07.016_bib83","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.3389\/fimmu.2020.01466","article-title":"A 34-Marker Panel for Imaging Mass Cytometric Analysis of Human Snap-Frozen Tissue","volume":"11","author":"Guo","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.immuni.2024.07.016_bib84","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-1-4939-9454-0_7","article-title":"Surface Barcoding of Live PBMC for Multiplexed Mass Cytometry","volume":"1989","author":"Schulz","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.immuni.2024.07.016_bib85","article-title":"ImcSegmentationPipeline: A pixelclassification based multiplexed image segmentation pipeline (v0.9)","author":"Vito","year":"2017","journal-title":"Zenodo"},{"key":"10.1016\/j.immuni.2024.07.016_bib86","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/s41592-019-0582-9","article-title":"ilastik: interactive machine learning for (bio)image analysis","volume":"16","author":"Berg","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.immuni.2024.07.016_bib87","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2144\/000112257","article-title":"CellProfiler: free, versatile software for automated biological image analysis","volume":"42","author":"Lamprecht","year":"2007","journal-title":"BioTechniques"},{"key":"10.1016\/j.immuni.2024.07.016_bib88","doi-asserted-by":"crossref","first-page":"5706","DOI":"10.1093\/bioinformatics\/btaa1061","article-title":"cytomapper: an R\/Bioconductor package for visualization of highly multiplexed imaging data","volume":"36","author":"Eling","year":"2021","journal-title":"Bioinformatics"},{"key":"10.1016\/j.immuni.2024.07.016_bib89","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.1038\/s41596-023-00881-0","article-title":"An end-to-end workflow for multiplexed image processing and analysis","volume":"18","author":"Windhager","year":"2023","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.immuni.2024.07.016_bib90","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1111\/all.15302","article-title":"Autoantibodies in COVID-19 correlate with antiviral humoral responses and distinct immune signatures","volume":"77","author":"Taeschler","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.immuni.2024.07.016_bib91","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nbt.3519","article-title":"Near-optimal probabilistic RNA-seq quantification","volume":"34","author":"Bray","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.immuni.2024.07.016_bib92","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.immuni.2024.07.016_bib93","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41586-021-04280-x","article-title":"Signature of long-lived memory CD8(+) T\u00a0cells in acute SARS-CoV-2 infection","volume":"602","author":"Adamo","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2024.07.016_bib94","doi-asserted-by":"crossref","DOI":"10.1126\/science.adg7942","article-title":"Persistent complement dysregulation with signs of thromboinflammation in active Long Covid","volume":"383","author":"Cervia-Hasler","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.immuni.2024.07.016_bib95","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2024.07.016_bib96","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1093\/bioinformatics\/btv359","article-title":"Change-O: a toolkit for analyzing large-scale B cell immunoglobulin repertoire sequencing data","volume":"31","author":"Gupta","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.immuni.2024.07.016_bib97","article-title":"CellChat for systematic analysis of cell-cell communication from single-cell and spatially resolved transcriptomics","author":"Jin","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.immuni.2024.07.016_bib98","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/s41592-021-01274-5","article-title":"Systematic investigation of cytokine signaling activity at the tissue and single-cell levels","volume":"18","author":"Jiang","year":"2021","journal-title":"Nat. Methods"},{"key":"10.1016\/j.immuni.2024.07.016_bib99","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/nmeth.2688","article-title":"Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position","volume":"10","author":"Buenrostro","year":"2013","journal-title":"Nat. Methods"},{"key":"10.1016\/j.immuni.2024.07.016_bib100","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/nmeth.4396","article-title":"An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues","volume":"14","author":"Corces","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.immuni.2024.07.016_bib101","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","article-title":"Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities","volume":"38","author":"Heinz","year":"2010","journal-title":"Mol. Cell"}],"container-title":["Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761324003650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761324003650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T17:24:05Z","timestamp":1762363445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1074761324003650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":101,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1074761324003650"],"URL":"https:\/\/doi.org\/10.1016\/j.immuni.2024.07.016","relation":{},"ISSN":["1074-7613"],"issn-type":[{"value":"1074-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin-2 immunotherapy reveals human regulatory T\u00a0cell subsets with distinct functional and tissue-homing characteristics","name":"articletitle","label":"Article Title"},{"value":"Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.immuni.2024.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}